Treatment Therapies in Pancreatic Carcinoma

Pancreatic cancer is the fourth leading cause of cancer deaths, being responsible for 7% of all cancer-related deaths in both men and women. Approximately 75% of all pancreatic carcinomas occur within the head or neck of the pancreas, 15-20% occurs in the body of the pancreas, and 5-10% occurs in the tail. Scientists are learning more about some of the changes in DNA that cause cells in the pancreas to become cancerous. Inherited changes in genes such as BRCA2, p16, and the genes responsible for hereditary non-polyposis colorectal cancer (HNPCC) can increase a person’s risk of developing pancreatic cancer.

  • Proton therapy
  • Radiation therapy
  • Chemotherapy
  • Immunotherapy
  • Ablation or embolization treatments

Related Conference of Treatment Therapies in Pancreatic Carcinoma

June 28-30, 2018

Euro Global Congress on HCV

Amsterdam, Netherlands
August 6-7, 2018

14th Annual Congress on Gastroenterology & Hepatology

Hyatt Regency Osaka, Japan
August 20-21, 2018

13th Euro-Global Gastroenterology Conference

Rome, Italy
September 7-8, 2018

18th World Gastroenterologists Summit

Auckland, New Zealand
September 17-18, 2018

3rd International Conference on Hepatobiliary & Pancreatic Disorders

| Philadelphia, Pennsylvania, USA
September 21-22, 2018

6th International Conference on Hepatology

Osaka, Japan
October 15-16, 2018

3rd World Liver Congress

Abu Dhabi, UAE
October 29-30, 2018

4th World Congress on Digestive & Metabolic Diseases

| San Francisco, California, USA
November 07-08, 2018

World Summit on Liver Cirrhosis and Hepatitis

Singapore
November 08-09, 2018

15th World Congress on Gastroenterology & Therapeutics

Auckland, Newzealand
March 04-06, 2019

20th World Congress on Gastroenterology

Berlin, Germany
April 28-29 2019,

World Liver Conference 2019

Chicago, U.S.A

Treatment Therapies in Pancreatic Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in